I85PREP
⌘ K
Internat Pharmacie (Côte d'Ivoire) study materials
Internat Pharmacie (Côte d'Ivoire) study resources

Internat Pharmacie (Côte d'Ivoire) practice questions

One question at a time. Build your Internat Pharmacie (Côte d'Ivoire) understanding.

First 50 of 190 questions. Each one lists the choices, the correct answer, and an explanation. The checker at the top of this page saves progress in this browser when it is available.

Continue in the practice tool above to load more questions, 50 at a time.

Question 1Pharmacodynamic targets, class effects and therapeutic limits

Which adrenergic receptor subtype is predominantly located on bronchial smooth muscle and vascular smooth muscle of skeletal muscle, mediating relaxation and bronchodilation upon activation (支气管平滑肌舒张)?

  1. Alpha-1 adrenergic receptor (α1受体)
  2. Beta-1 adrenergic receptor (β1受体)
  3. Alpha-2 adrenergic receptor (α2受体)
  4. Beta-2 adrenergic receptor (β2受体) Correct answer.

Explanation

Beta-2 adrenergic receptors (β2受体) are coupled to Gs proteins, stimulating adenylate cyclase to increase intracellular cAMP, which activates protein kinase A (PKA) and promotes smooth muscle relaxation. Activation of β2 receptors produces bronchodilation, vasodilation in skeletal muscle vascular beds, and glycogenolysis in the liver.

Question 2Pharmacodynamic targets, class effects and therapeutic limits

Which biochemical pathway and specific fungal enzyme are targeted by triazole antifungal agents such as fluconazole and voriconazole (三唑类抗真菌药作用靶点)?

  1. Inhibition of squalene epoxidase in squalene pathway
  2. Inhibition of cytochrome P450-dependent Lanosterol 14α-demethylase (CYP51 / 羊毛甾醇14α-去甲基酶) Correct answer.
  3. Inhibition of β-(1,3)-D-glucan synthase in cell wall assembly
  4. Inhibition of fungal DNA topoisomerase II

Explanation

Azole antifungals (triazoles like fluconazole, voriconazole, itraconazole) selectively inhibit fungal cytochrome P450-dependent Lanosterol 14α-demethylase (encoded by ERG11 / CYP51). This blocks the conversion of lanosterol to ergosterol, leading to ergosterol depletion and accumulation of toxic 14α-methylated sterols that disrupt fungal membrane permeability and inhibit fungal growth.

Question 3Pharmacokinetics, therapeutic monitoring and explicit calculation models

Which of the following metabolic transformations represents a Phase II conjugation reaction (第II相结合反应) in human drug metabolism?

  1. Aromatic hydroxylation catalyzed by Cytochrome P450 3A4 (CYP3A4芳环羟基化)
  2. Ester hydrolysis catalyzed by serum carboxylesterase (酯酶水解)
  3. Sulfoxidation catalyzed by flavin-containing monooxygenase (黄素单加氧酶硫氧化)
  4. Glucuronidation catalyzed by UDP-glucuronosyltransferase (UDP-葡萄糖醛酸转移酶结合反应) Correct answer.

Explanation

Drug metabolism is divided into Phase I functionalization reactions (oxidation, reduction, hydrolysis that introduce or unmask polar functional groups like -OH, -COOH, -NH2, -SH) and Phase II conjugation reactions (结合反应), where endogenous hydrophilic molecules such as glucuronic acid, sulfate, glutathione, glycine, or acetate are covalently attached to make metabolites highly water-soluble for renal or biliary excretion.

Question 4Pharmacokinetics, therapeutic monitoring and explicit calculation models

In pharmaceutical chiral chemistry, why does Esomeprazole (艾司奥美拉唑 / S-奥美拉唑) demonstrate superior systemic bioavailability and less inter-individual pharmacokinetic variability compared to the racemic mixture Omeprazole?

  1. The (S)-enantiomer undergoes significantly lower first-pass hepatic metabolism by CYP2C19 than the (R)-enantiomer, achieving higher AUC (S-异构体受CYP2C19代谢清除率显著低于R-异构体) Correct answer.
  2. The (S)-enantiomer binds irreversibly to gastric H+/K+-ATPase whereas the (R)-enantiomer is completely inactive
  3. The (S)-enantiomer is absorbed via active peptide transporters whereas the (R)-enantiomer is not absorbed
  4. The (R)-enantiomer causes competitive inhibition of the proton pump whereas the (S)-enantiomer acts as an allosteric opener

Explanation

Esomeprazole is the S-enantiomer and has relevant metabolic differences from the racemic comparison, which can alter systemic exposure under the specified conditions. Genetics, formulation, dose and interacting medicines also affect results. A stereochemical comparison does not guarantee identical improved exposure or therapeutic benefit in every person.

Question 5Dosage forms, formulation behavior and responsible preparation

Which oral solid dosage form utilizes a semipermeable membrane coating with laser-drilled delivery orifices to achieve constant, zero-order drug release driven by internal hydrostatic osmotic pressure (渗透泵控释片)?

  1. Enteric-Coated Delayed-Release Tablet (肠溶片)
  2. Osmotic Pump Controlled-Release Tablet (渗透泵控释制剂) Correct answer.
  3. Effervescent Disintegrating Tablet (泡腾片)
  4. Erodible Matrix Sustained-Release Tablet (溶蚀性骨架片)

Explanation

Osmotic pump tablets (渗透泵制剂, e.g., Nifedipine GITS / 硝苯地平控释片) consist of an active drug core surrounded by a rigid semipermeable membrane with a laser-drilled microscopic orifice. Water from gastrointestinal fluids permeates into the core, dissolving osmotic agents and generating hydrostatic pressure that pumps drug solution out through the orifice at a steady, zero-order release rate independent of gastrointestinal pH and motility.

Question 6Dosage forms, formulation behavior and responsible preparation

In semi-solid formulation science, what type of ointment base is exemplified by hydrophilic petrolatum and anhydrous lanolin (羊毛脂), capable of absorbing substantial amounts of water while remaining non-washable with water?

  1. Water-Soluble Polyethylene Glycol Base (水溶性PEG基质)
  2. Oil-in-Water Emulsion Base (O/W型乳剂基质 / 水包油型)
  3. Oleaginous Hydrocarbon Base (单纯烃类油脂性基质)
  4. Absorption / Emulsifiable Hydrocarbon Base (吸收性软膏基质) Correct answer.

Explanation

Absorption ointment bases (吸收性基质, e.g., anhydrous lanolin / 羊毛脂, hydrophilic petrolatum) consist of hydrocarbon or lipid bases combined with W/O emulsifiers (such as sterols or cholesterol). They can absorb significant quantities of aqueous solutions to form W/O emulsions, providing occlusive emollient protection.

Question 7Pharmaceutical analysis, identity, stability and quality evidence

In pharmaceutical analytical testing under the Chinese Pharmacopoeia (《中国药典》), which quantitative principle states that absorbance (A) is directly proportional to both absorption path length (b) and solution concentration (c) in UV-Vis spectrophotometry?

  1. Nernst Distribution Law (能斯特分配定律)
  2. Bragg's Law of X-ray Diffraction (布拉格定律)
  3. Lambert-Beer Law (朗伯-比尔定律: A = εbc) Correct answer.
  4. Fick's First Law of Diffusion (菲克第一扩散定律)

Explanation

The Lambert-Beer Law (朗伯-比尔定律) is the fundamental physical law governing UV-Vis absorption spectroscopy: A = E1%1cm * c * L (or A = εbc), where A is absorbance, ε is molar absorptivity, b is the optical path length in cm, and c is molar concentration. It forms the quantitative basis for spectrophotometric drug assay content determination.

Question 8Pharmaceutical analysis, identity, stability and quality evidence

In pharmaceutical manufacturing and hospital preparation of sterile injectables, which method is widely utilized for bacterial endotoxin testing (细菌内毒素检查) based on the gelation of amoebocyte lysate from the horseshoe crab?

  1. Rabbit Pyrogen Test (家兔发热试验法)
  2. Membrane filtration bioburden sterility test (薄膜过滤法无菌检查)
  3. Limulus Amebocyte Lysate assay (TAL/LAL assay / 鲎试剂法) Correct answer.
  4. High-Performance Liquid Chromatography (高效液相色谱法)

Explanation

The Limulus Amebocyte Lysate (LAL/TAL / 鲎试剂) test is the primary, highly sensitive in vitro assay specified in the Chinese Pharmacopoeia for detecting bacterial endotoxins (LPS from Gram-negative bacteria). Endotoxins activate clotting enzyme cascades in the amebocyte lysate from Tachypleus tridentatus or Limulus polyphemus, producing a firm gel clot or optical turbidity.

Question 9Medical biology, diagnostic evidence and sample interpretation

In human cellular physiology, which transport mechanism is responsible for moving Na+ out of the cell and K+ into the cell against their respective concentration gradients, consuming ATP in the process (主动转运)?

  1. Sodium-potassium adenosine triphosphatase pump (Na+/K+-ATPase 钠钾泵) Correct answer.
  2. Voltage-gated sodium channel facilitated diffusion (电压门控钠通道易化扩散)
  3. Simple lipid bilayer passive diffusion (简单扩散)
  4. Potassium leak channel passive efflux (钾漏通道被动外流)

Explanation

Primary active transport (原发性主动转运) moves ions across the plasma membrane against electrochemical gradients using energy directly derived from ATP hydrolysis. The Na+/K+-ATPase pump expels 3 Na+ ions from the intracellular compartment in exchange for importing 2 K+ ions per ATP molecule hydrolyzed, maintaining resting membrane potential and cell volume.

Question 10Medical biology, diagnostic evidence and sample interpretation

During the action potential of ventricular cardiac working myocytes (心室肌动作电位), which ionic current is primarily responsible for the characteristic Phase 2 plateau (2期平台期)?

  1. Fast inward Na+ current via Nav1.5 channels (INa)
  2. Inward Ca2+ current via L-type calcium channels (ICa-L) balanced by delayed rectifier outward K+ current (IK) Correct answer.
  3. Transient outward K+ current (Ito)
  4. Inward rectifier K+ current maintaining resting potential (IK1)

Explanation

Phase 2 (plateau phase / 平台期) of the ventricular cardiac action potential is characterized by a balance between the slow inward flow of Ca2+ through L-type calcium channels (ICa-L) and the outward flow of K+ through delayed rectifier potassium channels (IK). This prolonged plateau prolongs the effective refractory period (ERP), preventing tetanic cardiac contraction.

Question 11Clinical pharmacy review, counseling and safe escalation

A patient with acute coronary syndrome undergoes percutaneous coronary intervention (PCI) with drug-eluting stent placement. Genetic testing reveals the patient is a CYP2C19*2/*2 homozygous loss-of-function poor metabolizer (慢代谢型). Why is Clopidogrel (氯吡格雷) ineffective in this patient, and which P2Y12 inhibitor is guideline-recommended instead?

  1. Clopidogrel is toxic to CYP2C19 poor metabolizers causing acute hemolysis; Warfarin should be substituted
  2. Clopidogrel is an inactive prodrug requiring CYP2C19 bioactivation into its active thiol metabolite; Ticagrelor (替格瑞洛) is direct-acting and independent of CYP2C19 bioactivation (氯吡格雷需CYP2C19活化，应换用直接作用的替格瑞洛) Correct answer.
  3. Clopidogrel irreversibly blocks COX-1; Aspirin monotherapy should be used instead
  4. Clopidogrel is cleared too rapidly in CYP2C19*2 carriers; doubling the clopidogrel dose is the sole guideline recommendation

Explanation

Clopidogrel is a thienopyridine prodrug that requires a two-step hepatic bioactivation process, in which CYP2C19 plays the predominant role in forming the active thiol metabolite that irreversibly blocks the platelet P2Y12 ADP receptor. CYP2C19*2 and *3 alleles encode non-functional enzymes; homozygous poor metabolizers (*2/*2) cannot form sufficient active drug, leading to high on-treatment platelet reactivity and stent thrombosis. Ticagrelor (替格瑞洛) is a cyclopentyltriazolopyrimidine that is active without metabolic bioactivation, making it the preferred first-line agent.

Question 12Clinical pharmacy review, counseling and safe escalation

Aminoglycoside antibiotics (e.g., Gentamicin, Amikacin / 庆大霉素、阿米卡星) exhibit concentration-dependent killing and a significant Post-Antibiotic Effect (PAE / 抗生素后效应). What are their two principal organ toxicities that mandate clinical therapeutic drug monitoring?

  1. Ototoxicity (vestibulocochlear damage) and Nephrotoxicity (acute tubular necrosis) (耳毒性与肾毒性) Correct answer.
  2. Hepatotoxicity and Aplastic anemia
  3. Pulmonary fibrosis and Peripheral neuropathy
  4. Retinal macular degeneration and Tendon rupture

Explanation

Aminoglycosides selectively accumulate in the perilymph/endolymph of the inner ear and the proximal tubular epithelial cells of the renal cortex. They cause Ototoxicity (耳毒性 - permanent cochlear sensory hair cell damage and vestibular dysfunction causing hearing loss, tinnitus, and ataxia) and Nephrotoxicity (肾毒性 - typically non-oliguric acute tubular necrosis with elevated serum creatinine). Both toxicities correlate with elevated trough concentrations and prolonged treatment duration.

Question 13Dispensing systems, medication reconciliation and error prevention

In patient medication safety management, what operational strategy is required for Look-Alike Sound-Alike (LASA / 听似看似易混淆药品) and High-Alert Medications (高警示药品)?

  1. Physical segregation, conspicuous high-alert warning labels, tall-man lettering on electronic interfaces, and independent double-check verification prior to dispensing (分开放置、警示标识、高警示双人复核) Correct answer.
  2. Alphabetical co-shelving to minimize dispensary retrieval transit time
  3. Permitting verbal telephone orders without written read-back confirmation
  4. Dispensing without independent secondary verification in high-volume rush periods

Explanation

Patient safety standards mandated by the NHC and the Institute for Safe Medication Practices (ISMP) require that LASA drugs (e.g., vincristine vs vinblastine, ephedrine vs epinephrine) and high-alert medications (e.g., concentrated potassium chloride, 10% NaCl, insulin, heparin) must be stored in physically segregated bins with bold colored warning labels (警示标识), utilize tall-man lettering, and undergo mandatory independent double-checking (双人核对) before dispensing.

Question 14Dispensing systems, medication reconciliation and error prevention

A clinical pharmacist auditing an inpatient prescription notices an order for '10% Potassium Chloride Injection 10 mL via Direct Intravenous Bolus (静脉推注)'. What immediate intervention is required and why?

  1. Approve the prescription provided it is administered over 2 minutes
  2. Change the route to subcutaneous injection without physician consultation
  3. Intervene immediately to intercept the order: Direct intravenous push of concentrated potassium chloride causes acute cardiac arrest and is strictly prohibited; it must be diluted into intravenous infusions to a final concentration not exceeding 0.3% w/v (严禁直接静脉推注高浓度氯化钾，可致心脏骤停，输注浓度严禁超过0.3%) Correct answer.
  4. Approve the order if the patient has documented hypokalemia

Explanation

Concentrated Potassium Chloride (10% KCl) is a Class A High-Alert Medication (高警示药品). Direct intravenous push (静脉推注/静脉注射) causes sudden, massive hyperkalemia in the coronary circulation, depolarizing the cardiac resting membrane potential, abolishing cardiac automaticity and conduction, and inducing immediate fatal diastolic cardiac arrest (心脏骤停). Potassium chloride MUST be diluted in IV fluids (e.g., normal saline or 5% glucose) to a final concentration strictly ≤0.3% w/v (3 g KCl per 1000 mL fluid) and administered via controlled infusion at a rate not exceeding 20 mmol/h (1.5 g/h).

Question 15Evidence appraisal, calculations and pharmacy resource decisions

In hospital pharmacy inventory management, what is the Economic Order Quantity (EOQ / Formule de Wilson) used to determine, and how does the ABC analysis classify pharmaceutical inventory?

  1. EOQ determines the optimal order size that minimizes the sum of ordering costs and inventory holding/carrying costs; ABC analysis stratifies stock by annual consumption value (Class A = ~10–20% of items accounting for ~70–80% of total budget) Correct answer.
  2. EOQ calculates drug expiration dates; ABC analysis classifies drugs alphabetically by brand name
  3. EOQ determines the lethal dose 50 of toxic waste; ABC analysis sorts medicines by tablet shape
  4. EOQ calculates nurse salary deductions; ABC analysis sorts products by package weight

Explanation

The Wilson formula calculates the Economic Order Quantity: EOQ = sqrt((2 × Annual Demand × Ordering Cost) / Holding Cost per unit). ABC analysis applies Pareto's 80/20 principle to hospital pharmacy management: Class A items (high financial value, ~70–80% of expenditure, ~10–20% of line items) receive rigorous daily inventory control; Class B items (intermediate, ~15–20% value); Class C items (low financial value, ~5–10% value, ~60–70% of line items).

Question 16Pharmacy qualification roles, scientific references and local duties

In clinical pharmacy and patient safety, what is Medication Reconciliation (Conciliation des traitements médicamenteux / Medication reconciliation), and at what clinical transition points should it be systematically performed?

  1. A formal multidisciplinary process where the clinical pharmacist compiles the exhaustive Best Possible Medication History (BPMH) and compares it with active hospital prescriptions to detect and intercept unintended discrepancies, omissions, and duplications at hospital admission, intra-hospital transfer, and discharge Correct answer.
  2. A billing audit performed by hospital accounting at patient discharge
  3. Verification that the brand names match the hospital formulary exclusively
  4. A laboratory test measuring all drug concentrations in blood simultaneously

Explanation

Medication reconciliation (conciliation médicamenteuse) is a formalized patient safety process led by clinical pharmacists. By interviewing the patient, family, community pharmacist, and attending physician, the pharmacist establishes the Best Possible Medication History (BPMH / Bilan Médicamenteux Optimisé) and cross-references it with current hospital orders, identifying and correcting unintended discrepancies (omitted chronic therapies, dosing errors, duplicates) at admission, ward transfer, and discharge.

Question 17Pharmacodynamic targets, class effects and therapeutic limits

In receptor pharmacodynamics, how does a competitive antagonist (antagoniste compétitif) alter the concentration-response curve of a full agonist on a semi-logarithmic plot?

  1. Shifts the agonist concentration-response curve to the right (increasing EC50) without decreasing the maximal biological response (Emax remains unchanged) Correct answer.
  2. Shifts the curve to the left and increases maximal efficacy (Emax)
  3. Decreases the maximal biological response (Emax) without changing the EC50 (non-competitive antagonism)
  4. Flattens the baseline without altering the agonist binding affinity

Explanation

A competitive antagonist binds reversibly to the same orthosteric active site on the receptor as the agonist. Because the agonist and antagonist compete for the same site, increasing the concentration of the agonist can fully overcome the blockade, maintaining the maximum possible biological efficacy (Emax unchanged) while requiring higher agonist concentrations to achieve any given effect (parallel rightward shift of the curve, increasing EC50).

Question 18Pharmacodynamic targets, class effects and therapeutic limits

Beta-lactam antibiotics (penicillins, cephalosporins, carbapenems) are classic examples of time-dependent (temps-dépendant) bactericidal agents. What pharmacokinetic/pharmacodynamic (PK/PD) index best predicts their in vivo clinical efficacy and bacterial eradication?

  1. Percentage of the dosing interval that the free unbound drug concentration exceeds the Minimum Inhibitory Concentration (%fT > MIC / %T > CMI) Correct answer.
  2. Ratio of maximum peak serum concentration to the MIC (Cmax / MIC)
  3. Ratio of the 24-hour area under the concentration-time curve to the MIC (AUC24 / MIC)
  4. Peak serum concentration at 12 hours exclusively

Explanation

Beta-lactam killing activity depends on the duration of time that bacterial penicillin-binding proteins are continuously saturated by the antibiotic. Efficacy is optimized when free drug concentration remains above the pathogen's MIC (%fT > MIC) for at least 40–50% of the dosing interval for penicillins, 50–60% for cephalosporins, and 40% for carbapenems, favoring frequent dosing or continuous/extended infusions.

Question 19Pharmacodynamic targets, class effects and therapeutic limits

Which macrolide antibiotic is the weakest inhibitor of Cytochrome P450 3A4 (CYP3A4) and does not prolong the elimination of CYP3A4-metabolized drugs (such as carbamazepine, cyclosporine, or statins), unlike erythromycin and clarithromycin?

  1. Azithromycin (Azithromycine) Correct answer.
  2. Clarithromycin (Clarithromycine)
  3. Erythromycin (Érythromycine)
  4. Troleandomycin

Explanation

Azithromycin has less CYP3A4 inhibitory effect than the listed stronger macrolide comparators. That does not mean it has no clinically relevant interaction or adverse-effect potential. The actual medicines, patient and product information determine a real interaction assessment rather than a guarantee from the class comparison alone.

Question 20Pharmacodynamic targets, class effects and therapeutic limits

Which listed molecular mechanism describes dolutegravir as an HIV integrase strand-transfer inhibitor, without asserting one current national first-line regimen for every person?

  1. Inhibition of HIV-1 Integrase Strand Transfer (INSTI), blocking the insertion of retroviral proviral DNA into the host cell chromosomal genome Correct answer.
  2. Chain termination during retroviral reverse transcription by competing with natural deoxynucleotides (NRTI)
  3. Allosteric non-competitive inhibition of HIV reverse transcriptase (NNRTI)
  4. Inhibition of HIV aspartyl protease, preventing the cleavage of Gag-Pol polyproteins

Explanation

Dolutegravir is a second-generation Integrase Strand Transfer Inhibitor (INSTI). It coordinates divalent magnesium (Mg2+) cations in the catalytic core of the viral integrase enzyme, preventing the strand transfer reaction that integrates synthesized linear viral double-stranded proviral DNA into host chromosomal DNA, thereby halting productive replication.

Question 21Pharmacodynamic targets, class effects and therapeutic limits

In cardiovascular pharmacology, what is the key hemodynamic and pharmacological distinction between dihydropyridine calcium channel blockers (e.g., amlodipine, nifedipine) and non-dihydropyridines (e.g., verapamil, diltiazem)?

  1. Dihydropyridines act selectively as peripheral arterial vasodilators with minimal cardiac depressant effect, whereas non-dihydropyridines have potent negative inotropic, chronotropic, and dromotropic cardiac effects (slowing AV nodal conduction) Correct answer.
  2. Dihydropyridines cause severe bradycardia, whereas non-dihydropyridines cause reflex tachycardia
  3. Non-dihydropyridines are selective for renal efferent arterioles
  4. Dihydropyridines act as direct renin inhibitors

Explanation

Dihydropyridines (amlodipine, nicardipine, nifedipine) bind the transmembrane domain of vascular L-type calcium channels, acting as potent systemic arterial vasodilators that lower blood pressure (with peripheral ankle edema and possible reflex tachycardia). Non-dihydropyridines (verapamil, diltiazem) bind intracellular channel domains in the myocardium and AV node, producing potent negative inotropic (reducing contractility) and negative dromotropic (slowing AV conduction) effects.

Question 22Pharmacodynamic targets, class effects and therapeutic limits

Regarding the nephron site of action and electrolyte effects of diuretic classes, which pairing correctly matches the diuretic with its specific tubular transport target?

  1. Furosemide inhibits the Na+/K+/2Cl- cotransporter in the thick ascending limb of Henle's loop; Hydrochlorothiazide inhibits the Na+/Cl- cotransporter in the distal convoluted tubule Correct answer.
  2. Spironolactone inhibits carbonic anhydrase in the proximal tubule
  3. Acetazolamide blocks the epithelial sodium channel (ENaC) in the collecting duct
  4. Indapamide blocks the SGLT2 cotransporter in the loop of Henle

Explanation

Loop diuretics (furosemide, bumetanide) inhibit the apical Na+/K+/2Cl- symporter in the thick ascending limb of Henle, causing potent natriuresis, kaliuresis, and calciuria. Thiazide diuretics (hydrochlorothiazide, indapamide) inhibit the Na+/Cl- cotransporter in the early distal convoluted tubule, causing natriuresis and promoting renal calcium retention (hypocalciuria).

Question 23Pharmacodynamic targets, class effects and therapeutic limits

What is the primary pharmacological and clinical difference between Unfractionated Heparin (UFH / HNF) and Low-Molecular-Weight Heparins (LMWH / HBPM, e.g., enoxaparin, tinzaparin)?

  1. UFH binds antithrombin to inhibit both Factor IIa (thrombin) and Factor Xa in a 1:1 ratio requiring regular aPTT/TCA monitoring, whereas LMWH exhibits preferential anti-Factor Xa activity (anti-Xa:anti-IIa ratio 3:1 to 4:1) with predictable bioavailability and lower Heparin-Induced Thrombocytopenia (HIT) risk Correct answer.
  2. LMWH inhibits only Factor VII and requires daily INR monitoring
  3. UFH has 100% oral bioavailability and is administered orally without monitoring
  4. LMWH is cleared entirely by hepatic CYP3A4 metabolism

Explanation

UFH consists of polysaccharide chains of varying lengths (>18 saccharide units) that form a ternary bridge between antithrombin and thrombin (Factor IIa), neutralizing IIa and Xa equally (1:1 ratio) and requiring close monitoring via aPTT. LMWH (cleaved smaller fragments) cannot form the bridge required to inhibit thrombin efficiently, giving an anti-Xa:anti-IIa ratio of 3:1 to 4:1, predictable subcutaneous bioavailability, renal clearance, and a ~10-fold lower incidence of Heparin-Induced Thrombocytopenia (HIT/TIH).

Question 24Pharmacodynamic targets, class effects and therapeutic limits

Aspirin (acetylsalicylic acid) at low antiplatelet doses (75–100 mg/day) produces irreversible inhibition of platelet aggregation throughout the entire 8–10 day lifespan of circulating platelets. What is its exact molecular target in platelets?

  1. Irreversible acetylation of the Serine 529 residue of Cyclooxygenase-1 (COX-1), permanently blocking the synthesis of Thromboxane A2 (TXA2) Correct answer.
  2. Reversible inhibition of Cyclooxygenase-2 (COX-2) in vascular endothelial cells
  3. Irreversible antagonism of the platelet P2Y12 ADP receptor
  4. Direct inhibition of Glycoprotein IIb/IIIa integrin cross-linking

Explanation

Aspirin transfers an acetyl group covalently to the Serine 529 residue in the active site channel of platelet Cyclooxygenase-1 (COX-1). This permanently blocks the conversion of arachidonic acid to prostaglandin H2 and thromboxane A2 (a potent platelet aggregator and vasoconstrictor). Because anucleate platelets cannot synthesize new COX-1 protein, platelet function remains suppressed for their entire 8–10 day lifespan.

Question 25Pharmacokinetics, therapeutic monitoring and explicit calculation models

In basic pharmacokinetics, how is the Apparent Volume of Distribution (Vd) defined mathematically following an intravenous bolus dose (D), and what does a high Vd (>10–50 L/kg, e.g., amiodarone, chloroquine) indicate about tissue distribution?

  1. Vd = Dose / C0 (where C0 is the extrapolated initial plasma concentration at time zero); High Vd indicates extensive extravascular tissue uptake and intracellular/adipose binding with very low plasma drug concentration Correct answer.
  2. Vd = Clearance × Elimination half-life; High Vd indicates that the drug is restricted exclusively to the vascular plasma compartment
  3. Vd = Dose × Bioavailability; High Vd indicates extensive binding to circulating serum albumin
  4. Vd = AUC / Dose; High Vd indicates rapid renal clearance

Explanation

Apparent Volume of Distribution is defined as the theoretical volume of fluid required to contain the total administered dose of drug at the same concentration as in plasma: Vd = Dose / C0. A Vd vastly exceeding total body water (e.g., chloroquine Vd ~100–200 L/kg) indicates extensive lipophilicity, deep tissue sequestration, and intracellular binding with low free plasma concentrations.

Question 26Pharmacokinetics, therapeutic monitoring and explicit calculation models

In the supplied first-order accumulation model, approximately how many half-lives correspond to the rough 93.75-to-96.875-percent band near the limiting steady-state level, rather than requiring every point in that band to exceed 95 percent?

  1. 4 to 5 half-lives (approx. 93.75% to 96.875% of steady state) Correct answer.
  2. 1 half-life (50% of steady state)
  3. 10 to 12 half-lives
  4. Steady state is reached immediately with the first maintenance dose

Explanation

After n half-lives, the stipulated accumulated fraction is 1-(1/2)^n. Four gives 93.75 percent and five gives 96.875 percent, so the listed four-to-five range fits the revised band. Strictly exceeding 95 percent requires more than about 4.32 half-lives. These are model results, not an actual universal patient stabilization time.

Question 27Pharmacokinetics, therapeutic monitoring and explicit calculation models

Rifampicin, carbamazepine, phenobarbital, and St. John's wort (millepertuis) are potent inducers of which major hepatic cytochrome P450 isoenzyme, causing accelerated metabolism and therapeutic failure of oral contraceptives, antiretroviral protease inhibitors, and calcineurin inhibitors?

  1. Cytochrome P450 3A4 (CYP3A4) Correct answer.
  2. Cytochrome P450 2D6 (CYP2D6)
  3. Cytochrome P450 1A2 (CYP1A2)
  4. Cytochrome P450 2E1 (CYP2E1)

Explanation

CYP3A4 is the most abundant cytochrome P450 enzyme in the human liver and intestine, metabolizing >50% of all clinically prescribed drugs. Potent CYP3A4 inducers (rifampicin, carbamazepine, phenytoin, phenobarbital, St. John's wort) bind the Pregnane X Receptor (PXR), dramatically increasing CYP3A4 transcription and lowering plasma levels of oral contraceptives (unwanted pregnancy), HIV protease inhibitors, and cyclosporine.

Question 28Pharmacokinetics, therapeutic monitoring and explicit calculation models

A 58-year-old patient receiving high-dose intravenous morphine for cancer pain becomes stuporous with pinpoint pupils (miosis) and severe bradypnea (4 breaths/min). Intravenous naloxone is titrated, producing immediate return of spontaneous respiration and consciousness. Why must the patient be monitored continuously for at least 2 to 4 hours post-reversal?

  1. Naloxone has a very short elimination half-life (30–60 minutes) compared to most opioids (morphine t1/2 2–4 hours, methadone >24 hours), carrying a high risk of recurrent respiratory depression ('renarcotization') as naloxone clears Correct answer.
  2. Naloxone causes permanent irreversible destruction of mu-opioid receptors
  3. Naloxone triggers sudden hyperkalemic cardiac arrest at 2 hours post-dose
  4. Naloxone binds covalently to plasma albumin for 48 hours

Explanation

Naloxone is a competitive mu-opioid receptor antagonist with a very short elimination half-life of 30 to 60 minutes (and duration of action 45–90 minutes). Because the half-life of most opioids (morphine, oxycodone, methadone, fentanyl transdermal) is significantly longer, the antagonist will be cleared while toxic opioid concentrations persist, leading to dangerous 're-narcotization' and secondary respiratory arrest unless monitored and redosed or given as a continuous infusion.

Question 29Pharmacokinetics, therapeutic monitoring and explicit calculation models

Which listed properties can make therapeutic drug monitoring useful when measurements inform actual treatment benefit or harm, rather than being legally mandatory for every drug with those properties?

  1. Narrow therapeutic index, high inter-individual pharmacokinetic variability, clear relationship between plasma concentration and clinical efficacy/toxicity, and difficult-to-monitor clinical endpoints (e.g., aminoglycosides, vancomycin, lithium, tacrolimus) Correct answer.
  2. Wide therapeutic window with low toxicity (e.g., amoxicillin, paracetamol)
  3. Drugs with direct, easily measurable clinical biomarkers (e.g., blood pressure for antihypertensives, blood glucose for insulin)
  4. Over-the-counter vitamins and topical creams

Explanation

Therapeutic Drug Monitoring (TDM) is clinically indicated when all of the following criteria are met: 1) Narrow therapeutic index (small difference between therapeutic and toxic doses); 2) High inter-patient pharmacokinetic variability (variable absorption, metabolism, clearance); 3) Well-defined relationship between serum concentration and therapeutic/toxic effects; and 4) Lack of simple, immediate clinical endpoints to gauge response (e.g., vancomycin, aminoglycosides, lithium, phenytoin, digoxin, cyclosporine, theophylline).

Question 30Dosage forms, formulation behavior and responsible preparation

In solid dosage form technology (Pharmacie galénique), what are the primary functional roles of Microcrystalline Cellulose, Povidone (PVP), Croscarmellose sodium, and Magnesium Stearate in a tablet direct compression formulation?

  1. Microcrystalline cellulose = Diluent/Binder; Povidone = Binder; Croscarmellose sodium = Superdisintegrant; Magnesium stearate = Hydrophobic lubricant Correct answer.
  2. Microcrystalline cellulose = Lubricant; Povidone = Enteric coating; Croscarmellose = Flavoring agent; Magnesium stearate = Diluent
  3. Microcrystalline cellulose = Colorant; Povidone = Plasticizer; Croscarmellose = Preservative; Magnesium stearate = Wetting agent
  4. All four excipients function solely as osmotic matrix formers

Explanation

In tableting: 1) Microcrystalline cellulose (Avicel) provides bulk and dry binding capacity due to plastic deformation under compression; 2) Povidone (PVP) acts as a wet/dry binder promoting granule cohesion; 3) Croscarmellose sodium is a cross-linked cellulose superdisintegrant that swells rapidly in water to burst the tablet; 4) Magnesium stearate is a boundary hydrophobic lubricant that reduces friction between tablet surfaces and die tooling during ejection.

Question 31Dosage forms, formulation behavior and responsible preparation

During tablet compression on a high-speed rotary press, what is the manufacturing defect termed 'Capping' (Calottage), and what are its common formulation and mechanical causes?

  1. Partial or complete detachment of the top or bottom crown (cap) of a tablet from the main body; Caused by excessive air entrapment during compression, excessive fine powder (fines), low moisture content, or excessive punch compression force Correct answer.
  2. Sticking of the tablet mass to the punch face due to damp granules
  3. Uneven distribution of colorant across the tablet surface (mottling)
  4. Separation of a tablet into multiple horizontal layers due to excessive oil

Explanation

Capping (calottage) is the partial or complete separation of the upper or lower crown of a tablet from the cylindrical body during or immediately after ejection. It is caused by elastic recovery of trapped air in the die, excessive fine powder fraction (>20–30%), overly dry granules, or worn die bores with deep punch penetration rings.

Question 32Dosage forms, formulation behavior and responsible preparation

According to the Biopharmaceutics Classification System (BCS / Système de Classification Biopharmaceutique), what are the solubility and intestinal permeability characteristics of a BCS Class II drug (e.g., ibuprofen, carbamazepine, ketoconazole), and what is the rate-limiting step for its in vivo absorption?

  1. Low Solubility, High Permeability; The rate-limiting step for systemic absorption is in vivo dissolution rate in gastrointestinal fluids Correct answer.
  2. High Solubility, High Permeability; The rate-limiting step is gastric emptying
  3. High Solubility, Low Permeability; The rate-limiting step is mucosal membrane permeation
  4. Low Solubility, Low Permeability; The drug cannot be formulated into solid dosage forms

Explanation

The BCS categorizes drugs into 4 classes: Class I (High Solubility, High Permeability), Class II (Low Solubility, High Permeability), Class III (High Solubility, Low Permeability), and Class IV (Low Solubility, Low Permeability). For BCS Class II drugs, membrane permeation is rapid, but systemic bioavailability is strictly limited by the rate and extent of drug dissolution in aqueous gastrointestinal fluids.

Question 33Dosage forms, formulation behavior and responsible preparation

In the formulation of pharmaceutical emulsions, how does the Hydrophilic-Lipophilic Balance (HLB / RHLB de Griffin) guide the selection of surfactants for Oil-in-Water (O/W / H/E) versus Water-in-Oil (W/O / E/H) emulsions?

  1. Lipophilic surfactants with low HLB values (3 to 6, e.g., Span / sorbitan esters) stabilize W/O emulsions; Hydrophilic surfactants with high HLB values (8 to 16, e.g., Tween / polysorbates) stabilize O/W emulsions Correct answer.
  2. High HLB (12–18) surfactants stabilize W/O emulsions exclusively
  3. HLB values have no relationship to emulsion type and apply only to dry powders
  4. Low HLB (1–3) surfactants act exclusively as water-soluble solubilizing agents

Explanation

Griffin's HLB scale ranges from 1 to 20 based on the molecular balance of hydrophilic and lipophilic groups: 1) Hydrophobic/lipophilic surfactants (HLB 3–6, e.g., sorbitan monooleate / Span 80) partition into the external oil phase, forming Water-in-Oil (W/O) emulsions; 2) Hydrophilic surfactants (HLB 8–16, e.g., polysorbate 80 / Tween 80) partition into the external aqueous phase, forming Oil-in-Water (O/W) emulsions (Bancroft's rule).

Question 34Dosage forms, formulation behavior and responsible preparation

In Total Parenteral Nutrition (TPN / Nutrition Parentérale Totale) compounding, what dangerous physico-chemical precipitation reaction between inorganic electrolytes must be strictly prevented through proper mixing sequence and solubility curve verification?

  1. Dibasic calcium phosphate (CaHPO4) precipitation forming insoluble microcrystals when calcium and inorganic phosphate concentrations exceed solubility product thresholds Correct answer.
  2. Sodium chloride crystallization at physiological pH
  3. Magnesium sulfate vaporization causing container explosion
  4. Potassium gluconate polymerization into rigid gel

Explanation

Calcium and inorganic phosphate in TPN admixtures can react to form dibasic calcium phosphate (CaHPO4), an insoluble precipitate. If infused, calcium phosphate microcrystals cause fatal pulmonary microembolism. Precipitation is prevented by: adding phosphate first, amino acids as buffer, and calcium last; using organic calcium salts (calcium gluconate rather than calcium chloride); and maintaining acidic pH and low storage temperatures.

Question 35Dosage forms, formulation behavior and responsible preparation

In transdermal drug delivery systems (Dispositifs Transdermiques / Patchs), what is the primary rate-limiting biological barrier to drug permeation across human skin, and what physicochemical drug properties favor passive transdermal absorption?

  1. Stratum corneum (couche cornée); Favorable drug properties: low molecular weight (<500 Da), moderate lipophilicity (log P between 1 and 3), low melting point, and high potency (daily dose <10–20 mg/day) Correct answer.
  2. Dermis layer; Favorable properties: high molecular weight (>50,000 Da) and extreme hydrophilicity
  3. Subcutaneous adipose tissue; Favorable properties: permanent ionic charge at physiological pH
  4. Stratum basale; Favorable properties: insoluble protein aggregates

Explanation

The stratum corneum (the outermost 10–20 μm layer of keratinized, lipid-embedded dead corneocytes in a 'bricks and mortar' arrangement) is the principal barrier to percutaneous absorption. Passive transdermal drug delivery is feasible only for molecules that can diffuse through lipid bilayers: low molecular weight (<500 Da), moderate lipophilicity (log P 1–3), low ionization at skin pH, and high pharmacological potency (e.g., fentanyl, nicotine, scopolamine, nitroglycerin, estradiol).

Question 36Dosage forms, formulation behavior and responsible preparation

In modified-release solid dosage forms, what functional polymers are utilized for Enteric Coating (Enrobage gastro-résistant / entérique, e.g., for omeprazole or enteric aspirin), and what is their pH-dependent solubility mechanism?

  1. Polymers with free carboxylic acid groups (e.g., Cellulose Acetate Phthalate, Hydroxypropyl Methylcellulose Phthalate, Methacrylic Acid Copolymers / Eudragit L and S); Insoluble in acidic gastric juice (pH 1.2), but dissolve upon ionization at neutral/alkaline intestinal pH (>5.5 to 7.0) Correct answer.
  2. Water-soluble methylcellulose that dissolves immediately in the mouth
  3. Pure beeswax that never dissolves in the human gastrointestinal tract
  4. Gelatin cross-linked with formaldehyde that dissolves only in the esophagus

Explanation

Enteric coatings protect acid-labile drugs from gastric degradation (e.g., proton pump inhibitors) or protect the stomach from irritating drugs (e.g., aspirin, NSAIDs). They utilize polycarboxylic polymers (cellulose acetate phthalate, Eudragit L100-55, HPMCP). In the acidic stomach (pH 1–3), carboxylic acid groups remain un-ionized and unionized polymers are completely insoluble; upon entering the duodenum (pH >5.5–6.0), the carboxyl groups ionize into carboxylate anions, dissolving the polymer shell and releasing the drug.

Question 37Pharmaceutical analysis, identity, stability and quality evidence

According to the Beer-Lambert Law (Loi de Beer-Lambert) in UV-Visible spectrophotometry (A = ε × b × c), which of the following represents the correct definition of terms and the primary physicochemical condition required for strict linearity between Absorbance and Concentration?

  1. A = Absorbance (dimensionless), ε = Molar absorptivity (L*mol^-1*cm^-1), b = optical path length (cm), c = concentration (mol/L); Linearity strictly requires monochromatic incident light and dilute solutions (absorbance typically 0.2 to 0.8) without chemical association/dissociation of the analyte Correct answer.
  2. A = Concentration, ε = Voltage, b = Wavelength, c = Temperature; Linearity holds only in concentrated opaque solutions
  3. Absorbance increases exponentially with decreasing optical path length
  4. Molar absorptivity varies randomly with changes in solute concentration

Explanation

The Beer-Lambert law states that Absorbance A = ε × b × c. Linearity holds true under specific conditions: monochromatic light, dilute solutions (typically concentration <0.01 M where refractive index and intermolecular electrostatic interactions remain constant), absence of stray light, and absence of chemical changes (solute ionization, dimerization, or photolysis).

Question 38Pharmaceutical analysis, identity, stability and quality evidence

In molecular spectrofluorimetry (Spectrofluorimétrie), what is the Stokes shift (Déplacement de Stokes), and why does fluorescence emission always occur at a longer wavelength (lower energy) than the excitation wavelength?

  1. The Stokes shift is the wavelength difference between the excitation maximum and emission maximum; Emission occurs at a longer wavelength because absorbed photonic energy is partially lost through non-radiative internal conversion and vibrational relaxation before fluorescence photon emission Correct answer.
  2. Emission occurs at a shorter wavelength because molecules gain thermal kinetic energy from the solvent
  3. The Stokes shift is the ratio of molecular weight to optical rotation
  4. Fluorescence emission and excitation always occur at the identical wavelength

Explanation

When a fluorophore absorbs a photon of light at its excitation wavelength, an electron is promoted to an excited singlet electronic state (S1 or S2). The molecule rapidly undergoes non-radiative vibrational relaxation (Kasha's rule) to the lowest vibrational level of S1, losing some energy as heat. The subsequent radiative transition from S1 back to the ground state S0 emits a photon of lower energy, and therefore longer wavelength (E = hc/λ), known as the Stokes shift.

Question 39Pharmaceutical analysis, identity, stability and quality evidence

In Infrared (IR) spectroscopy of organic pharmaceutical molecules, which characteristic vibrational absorption band is pathognomonic for a Carbonyl group (C=O stretch), and which region of the IR spectrum (<1500 cm^-1) provides unique structural identification (Fingerprint region / Zone des empreintes digitales)?

  1. Strong intense sharp absorption band at 1650 to 1750 cm^-1; Fingerprint region from 400 to 1500 cm^-1 containing complex single-bond skeletal bending vibrations Correct answer.
  2. Broad absorption band at 3200 to 3600 cm^-1; Fingerprint region at 3000 to 4000 cm^-1
  3. Weak absorption band at 2100 to 2260 cm^-1; Fingerprint region at 2000 to 2500 cm^-1
  4. Absorption at 800 to 900 cm^-1; Fingerprint region at 10 to 50 cm^-1

Explanation

The carbonyl group (C=O) produces a very strong, prominent stretching band between 1650–1750 cm^-1 (ketones, aldehydes, esters, amides, carboxylic acids). The fingerprint region (400–1500 cm^-1) reflects complex coupled skeletal stretching and bending vibrations unique to the entire molecular structure (no two distinct compounds except enantiomers have identical fingerprint spectra).

Question 40Pharmaceutical analysis, identity, stability and quality evidence

In Mass Spectrometry (MS), what is the key distinction between Electron Ionization (EI) and Electrospray Ionization (ESI), and why is ESI preferred for analyzing polar, thermolabile pharmaceuticals and intact biopharmaceuticals?

  1. EI is a 'hard' ionization method using high-energy electrons (70 eV) causing extensive molecular fragmentation; ESI is a 'soft' atmospheric-pressure ionization method producing intact protonated/deprotonated pseudomolecular ions [M+H]+ without thermal decomposition Correct answer.
  2. EI produces only multiply charged intact proteins; ESI vaporizes metals exclusively
  3. EI operates under atmospheric pressure; ESI operates under ultra-high vacuum with laser ablation
  4. Both methods produce identical fragmentation patterns without intact molecular ions

Explanation

Electron Ionization (EI) accelerates 70 eV electrons to knock out an electron from gas-phase molecules, imparting massive excess internal energy that causes extensive covalent fragmentation (useful for library matching of small volatiles in GC-MS). Electrospray Ionization (ESI) is a 'soft' atmospheric-pressure desorption technique that aerosolizes liquid droplets, generating intact protonated [M+H]+ or multiply charged ions [M+nH]n+ with minimal fragmentation, ideal for polar, high-molecular-weight, and thermolabile biologics (LC-MS).

Question 41Pharmaceutical analysis, identity, stability and quality evidence

In Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC), what are the standard characteristics of the stationary phase and mobile phase, and what is the elution order of compounds based on polarity?

  1. Stationary phase is non-polar (e.g., C18 / octadecylsilane silica); Mobile phase is polar (e.g., water/acetonitrile mixtures); Polar compounds elute first, followed by increasingly non-polar (lipophilic) compounds Correct answer.
  2. Stationary phase is highly polar (pure silica); Mobile phase is non-polar (hexane); Non-polar compounds elute first
  3. Stationary phase is positively charged; Mobile phase is pure chloroform; Compounds elute by molecular size only
  4. Stationary phase is liquid mercury; Mobile phase is compressed helium gas

Explanation

In Reversed-Phase HPLC (RP-HPLC), the stationary phase is non-polar / hydrophobic (silica covalently bonded with C18 octadecyl or C8 octyl hydrocarbon chains), while the mobile phase is polar (water or aqueous buffer mixed with organic modifiers like acetonitrile or methanol). Solutes partition based on hydrophobicity: polar, hydrophilic compounds have weak interactions with C18 and elute first, whereas lipophilic, non-polar compounds are strongly retained and elute last.

Question 42Pharmaceutical analysis, identity, stability and quality evidence

In Gas Chromatography (GC / CPG), which universal ionization detector responds to virtually all carbon-containing organic molecules by burning the effluent in a hydrogen-air flame to generate collectible ions?

  1. Flame Ionization Detector (FID / Détecteur à ionisation de flamme) Correct answer.
  2. Thermal Conductivity Detector (TCD / Catharomètre)
  3. Electron Capture Detector (ECD)
  4. Nitrogen-Phosphorus Detector (NPD)

Explanation

The Flame Ionization Detector (FID) is the most widely used detector in GC for organic pharmaceuticals. Effluent from the column is mixed with hydrogen and air and burned in a micro-flame, pyrolyzing hydrocarbons into CH* radicals and generating electrons and CHO+ ions collected by an electrode, producing a current proportional to the number of reduced carbon atoms.

Question 43Pharmaceutical analysis, identity, stability and quality evidence

In Thin-Layer Chromatography (TLC / CCM), how is the Retardation Factor (Rf) defined, and what is its possible numerical range?

  1. Rf = Distance migrated by solute spot / Distance migrated by solvent front; Value always ranges between 0.0 and 1.0 Correct answer.
  2. Rf = Distance migrated by solvent front / Distance migrated by solute; Value is always >1.0
  3. Rf = Spot diameter × Concentration; Value ranges from 0 to 100
  4. Rf = Retention time in minutes

Explanation

The retention factor (Rf / rapport frontal) in planar chromatography (TLC/paper) is the ratio of the distance travelled by the center of the solute spot from the origin line to the distance travelled by the mobile phase solvent front from the origin line. Because solutes cannot migrate faster than the solvent front, Rf is a dimensionless ratio strictly between 0.0 and 1.0.

Question 44Pharmaceutical analysis, identity, stability and quality evidence

According to the Henderson-Hasselbalch equation (pH = pKa + log([A-]/[HA])), what is the pH of a buffer solution containing equal molar concentrations of acetic acid (CH3COOH) and sodium acetate (CH3COONa) if the pKa of acetic acid is 4.76, and at what pH is the buffer capacity (pouvoir tampon) maximal?

  1. pH = 4.76; Buffer capacity is maximal when pH = pKa ([A-] = [HA]) Correct answer.
  2. pH = 7.00; Buffer capacity is maximal at neutrality
  3. pH = 1.00; Buffer capacity is maximal at pH 0
  4. pH = 9.52; Buffer capacity is maximal when pH = 2 × pKa

Explanation

Using Henderson-Hasselbalch: pH = pKa + log([A-]/[HA]). When [A-] = [HA], log(1) = 0, so pH = pKa = 4.76. The buffer capacity (beta / pouvoir tampon, resistance to pH change upon addition of acid or base) is mathematically maximal at pH = pKa, and the effective buffer range extends across pH = pKa ± 1.

Question 45Pharmaceutical analysis, identity, stability and quality evidence

In potentiometric acid-base titrations, what are the standard working electrode (indicator electrode) and reference electrode commonly combined in a modern single-body combination pH electrode?

  1. Glass membrane indicator electrode (generating potential proportional to H+ activity) combined with a Silver/Silver Chloride (Ag/AgCl) or Saturated Calomel (SCE) reference electrode Correct answer.
  2. Platinum indicator electrode combined with a Gold reference electrode
  3. Dropping mercury electrode combined with a carbon paste electrode
  4. Copper wire indicator electrode combined with an aluminum reference electrode

Explanation

A standard combination pH electrode contains: 1) A thin glass membrane indicator electrode with an internal buffer (0.1 M HCl) that develops an electrical phase-boundary potential according to the Nernst equation (59.16 mV per pH unit at 25°C) proportional to hydronium ion activity (H+), and 2) An Ag/AgCl reference electrode in saturated KCl providing a constant, stable reference potential through a porous ceramic liquid junction.

Question 46Pharmaceutical analysis, identity, stability and quality evidence

In complexometric titrations according to the European Pharmacopoeia, what is the stoichiometry of metal-EDTA complex formation (e.g., titrating Calcium Ca2+ or Magnesium Mg2+ with Disodium Edetate), and what metallochromic indicator is classically used at pH 10?

  1. Strict 1:1 molar stoichiometry regardless of the metal cation's valence; Eriochrome Black T (NET / Noir Ériochrome T) indicator at pH 10 ammoniacal buffer Correct answer.
  2. 1:2 molar stoichiometry (1 metal binds 2 EDTA molecules); Phenolphthalein indicator
  3. 2:1 molar stoichiometry; Methyl orange indicator
  4. 1:4 molar stoichiometry; Starch indicator

Explanation

Ethylenediaminetetraacetic acid (EDTA) is a hexadentate chelating ligand that wraps around metal ions via its two amine nitrogens and four carboxylate oxygens, forming an extremely stable, water-soluble octahedral chelate in a strict 1:1 stoichiometry [M-EDTA] regardless of metal oxidation state (+1, +2, +3, +4). At pH 10 (ammonia buffer), Eriochrome Black T binds free Ca2+/Mg2+ (wine red) and turns clear sky blue when EDTA chelates all metal at the endpoint.

Question 47Pharmaceutical analysis, identity, stability and quality evidence

In redox titrimetry, what is the chemical principle of Iodometry (indirect titration of oxidizing agents), and what indicator produces a sharp dark blue-black complex with free elemental iodine (I2 / I3-)?

  1. Oxidizing agents react with excess iodide (I-) to liberate equivalent elemental iodine (I2), which is then titrated with standardized Sodium Thiosulfate (Na2S2O3); Starch solution (Empois d'amidon) indicator added near the endpoint Correct answer.
  2. Direct titration of reducing agents with potassium permanganate without indicators
  3. Precipitation of silver iodide using fluorescein indicator
  4. Titration with cerium sulfate using phenolphthalein

Explanation

In indirect iodometry, an analyte oxidizing agent oxidizes excess potassium iodide (I-) into elemental iodine (I2 + I- -> I3-). The liberated triiodide is then titrated against standard sodium thiosulfate: I3- + 2 S2O3(2-) -> 3 I- + S4O6(2-) (tetrathionate). Starch indicator forms a deeply colored blue-black inclusion complex with triiodide inside the amylose helical structure; when the last trace of iodine is reduced at the endpoint, the solution turns abruptly colorless.

Question 48Pharmaceutical analysis, identity, stability and quality evidence

The Karl Fischer titration (Dosage de l'eau selon Karl Fischer) is the official pharmacopoeial method for the quantitative determination of trace water content in active pharmaceutical ingredients. What is the fundamental stoichiometric chemical reaction involved?

  1. Oxidation of sulfur dioxide (SO2) by iodine (I2) in the presence of water, a base (imidazole/pyridine), and an alcohol (methanol): H2O + I2 + SO2 + 3 Base + ROH -> 2 Base*HI + Base*HSO4R Correct answer.
  2. Hydrolysis of sodium chloride generating chlorine gas
  3. Dehydration of sulfuric acid by phosphorus pentoxide
  4. Precipitation of calcium carbonate by carbon dioxide

Explanation

Karl Fischer titration selectively consumes water according to a two-step Bunsen reaction: 1) SO2 reacts with alcohol (ROH) and base to form an alkylsulfite intermediate; 2) The alkylsulfite is oxidized by iodine (I2) in the presence of water: H2O + I2 + [BaseH]+[ROSO2]- + 2 Base -> [BaseH]+[ROSO3]- + 2 [BaseH]+I-. Because exactly 1 mole of I2 reacts with 1 mole of H2O, measuring consumed iodine (volumetrically or coulometrically via Faraday's law Q = 2nF) quantifies trace water accurately.

Question 49Pharmaceutical analysis, identity, stability and quality evidence

Which listed conventional analytical detection-limit approach describes sensitivity using a signal-to-noise or standard-deviation/slope model, rather than claiming an old named edition is the complete current validation standard?

  1. LOD corresponds to a Signal-to-Noise ratio of 3:1, or mathematically LOD = 3.3 × sigma / S (where sigma is the standard deviation of the intercept and S is the slope of the calibration curve) Correct answer.
  2. LOD corresponds to a Signal-to-Noise ratio of 10:1 (LOD = 10 × sigma / S)
  3. LOD is the concentration where recovery is exactly 100%
  4. LOD is the highest concentration on the linear calibration curve

Explanation

Under ICH Q2(R1), the Limit of Detection (LOD / LD) is the lowest amount of analyte in a sample that can be detected but not necessarily quantitated as an exact value. It is established by a Signal-to-Noise ratio of 3:1, or calculated as LOD = 3.3 × (sigma / S). In contrast, the Limit of Quantitation (LOQ / LQ) is defined by a Signal-to-Noise ratio of 10:1 (LOQ = 10 × sigma / S).

Question 50Pharmaceutical analysis, identity, stability and quality evidence

In pharmaceutical analytical validation (ICH Q2), what is the difference between Repeatability (Répétabilité / intra-assay precision) and Intermediate Precision (Précision intermédiaire)?

  1. Repeatability expresses precision under identical operating conditions over a short interval of time (same analyst, same instrument, same day); Intermediate Precision expresses within-laboratory variations (different days, different analysts, different equipment) Correct answer.
  2. Repeatability involves different international laboratories; Intermediate precision involves a single injection
  3. Repeatability measures trueness; Intermediate precision measures linearity
  4. There is no distinction; both terms are strictly interchangeable

Explanation

ICH Q2 defines three levels of precision: 1) Repeatability (intra-assay precision): testing under the same operating conditions (same operator, same apparatus, same laboratory, short time interval); 2) Intermediate precision: testing within the same laboratory on different days, with different analysts, or on different instruments; and 3) Reproducibility: testing between different independent laboratories (inter-laboratory collaborative study).